Bausch Hopes B+L Spin-Out Will 'Unlock' The Value Of Eye-Care Business

 
• By Joseph Haas

Bausch Health is paying down its debt with a $630m IPO for its Bausch + Lomb eyecare product business.

• Source: Alamy

More from Strategy

More from Business